Article Details
Retrieved on: 2021-01-07 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Enteris BioPharma's most advanced internal product candidate, Ovarest® (oral leuprolide tablet), is an oral peptide being developed for the treatment of ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here